EW
BIIB icon

Evoke Wealth’s Biogen BIIB Stock Holding History

Evoke Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,831
Closed -$2.54M – 74
2026
Q1 		$2.54M Buy
13,831
+288
+2% +$53.1K 0.05% 157
2025
Q4 		$2.38M Buy
13,543
+171
+1% +$27.9K 0.04% 158
2025
Q3 		$1.87M Buy
13,372
+225
+2% +$30.4K 0.04% 176
2025
Q2 		$1.65M Buy
13,147
+1,317
+11% +$164K 0.04% 183
2025
Q1 		$1.62M Buy
11,830
+262
+2% +$37.5K 0.04% 152
2024
Q4 		$1.77M Buy
11,568
+112
+1% +$18.9K 0.05% 140
2024
Q3 		$2.22M Buy
11,456
+7,916
+224% +$1.66M 0.06% 116
2024
Q2 		$821K Sell
3,540
-7,288
-67% -$1.58M 0.97% 21
2024
Q1 		$2.33M Buy
+10,828
New +$2.54M 0.07% 101
2023
Q2 		– Sell
-7,069
Closed -$1.97M – 366
2023
Q1 		$1.97M Buy
7,069
+5
+0.1% +$1.38K 0.07% 109
2022
Q4 		$1.96M Buy
+7,064
New +$2M 0.07% 116
2022
Q2 		– Sell
-362
Closed -$76K – 1177
2022
Q1 		$76K Buy
362
+324
+853% +$70.5K ﹤0.01% 467
2021
Q4 		$9K Hold
38
– – ﹤0.01% 800
2021
Q3 		$10K Sell
38
-12
-24% -$3.93K ﹤0.01% 737
2021
Q2 		$17K Buy
50
+5
+11% +$1.51K ﹤0.01% 675
2021
Q1 		$13K Hold
45
– – ﹤0.01% 646
2020
Q4 		$11K Hold
45
– – ﹤0.01% 569
2020
Q3 		$13K Hold
45
– – ﹤0.01% 524
2020
Q2 		$12K Sell
45
-3
-6% -$902 ﹤0.01% 524
2020
Q1 		$15.2K Sell
48
-392
-89% -$119K ﹤0.01% 469
2019
Q4 		$131K Sell
440
-747
-63% -$207K 0.02% 288
2019
Q3 		$276K Buy
+1,187
New +$276K 0.03% 212

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Evoke Wealth's BIIB Position: Q2 2026 in Review

Evoke Wealth sold out of Biogen (BIIB) in Q2 2026, closing a stake of 13,831 shares — an estimated $2.54M sold.

Evoke Wealth first reported a position in BIIB in Q3 2019 and held it in 22 quarters. The position peaked at $2.54M in Q1 2026. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Evoke Wealth reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
  • Evoke Wealth sold 13,831 Biogen shares in Q2 2026, an estimated $2.54M.
  • Evoke Wealth first reported a position in Biogen in Q3 2019 and held it in 22 quarters.
  • Evoke Wealth's Biogen position peaked at $2.54M in Q1 2026.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.